￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed instructions on discontinuation methods and precautions for Asnib/Asiminib

2026-02-01 22:25:32

Check Details
Things to note and operating guidelines while taking ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Whether sparsentan (sparsentan) needs to be taken continuously and the discontinuation plan

2026-02-01 22:25:32

Check Details
Detailed explanation of Ixazomib (Enleri) onset time and treatment course observation recommendations

2026-02-01 22:25:32

Check Details
Analysis of indications and clinical application scope of rubitin/rubicatin (Zanbiga)

2026-02-01 22:25:32

Check Details
The latest research progress and future clinical application prospects of Pimitespib

2026-02-01 22:25:32

Check Details
Afatinib (Gitairin) drug interactions and precautions for co-administration

2026-02-01 22:25:32

Check Details
Analysis of patients’ real medication experience and effect feedback of DaliRasen (Keweike)

2026-02-01 22:25:32

Check Details
Comparative analysis of the efficacy and safety of Lynparza and Pamiparib

2026-02-01 22:25:32

Check Details
Venetoclax/Venetoclax (Vekela) contraindications and instructions for those who should take it with caution

2026-02-01 22:25:32

Check Details
Possible drug resistance to Asnib/Aximinib (Sinbel) and treatment options for worsening

2026-02-01 22:25:32

Check Details
Detailed description of the storage conditions and drug preservation methods of Ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Category
相关知识